{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:42:38Z","timestamp":1787319758335,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Our goal was to conduct a scoping review of the literature on the treatment of infection-triggered encephalopathy syndrome\/acute encephalopathy in children, focusing on treatment targets and treatment initiation timing. We performed literature searches using PubMed for articles reporting treatments of infection-triggered encephalopathy syndrome\/acute encephalopathy. We included articles describing specific treatments for acute encephalopathy with control groups. For the purpose of searching new therapies only experimentally tried in the case series, we also included case series studies without control groups in this review, if the studies contained at least two cases with clear treatment goals. Therapies were classified based on their mechanisms of action into brain protection therapy, immunotherapy, and other therapies. We operationally categorized the timing of treatment initiation as T1 (6\u201312\u2009h), T2 (12\u201324\u2009h), T3 (24\u201348\u2009h), and T4 (&amp;gt;48\u2009h) after the onset of seizures and\/or impaired consciousness. Thirty articles were included in this review; no randomized control study was found. Eleven retrospective\/historical cohort studies and five case\u2013control studies included control groups with or without specific therapies or outcomes. The targeted conditions and treatment timing varied widely across studies. However, the following three points were suggested to be effective in multiple studies: (1) Careful seizure management and targeted temperature management within 12\u2009h (T1) of onset of febrile seizure\/prolonged impaired consciousness without multiple organ failure may reduce the development of acute encephalopathy with biphasic seizures and late reduced diffusion; (2) immunotherapy using corticosteroids, tocilizumab, or plasma exchange within 24\u2009h (T1\u2013T2) of onset of acute necrotizing encephalopathy may reduce sequelae; and (3) anakinra therapy and ketogenic diet demonstrate little evidence of neurologic sequelae reduction, but may reduce seizure frequency and allow for weaning from barbiturates, even when administered weeks (T4) after onset in children with febrile infection-related epilepsy syndrome. Although available studies have no solid evidence in the treatment of infection-triggered encephalopathy syndrome\/acute encephalopathy, this scoping review lays the groundwork for future prospective clinical trials.<\/jats:p>","DOI":"10.3389\/fnins.2023.1150868","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T03:10:23Z","timestamp":1692673823000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Timing of therapeutic interventions against infection-triggered encephalopathy syndrome: a scoping review of the pediatric literature"],"prefix":"10.3389","volume":"17","author":[{"given":"Hiroaki","family":"Nagase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Tokumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azusa","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00003246-197709000-00005","article-title":"Management of Reye's syndrome. A rational approach to a complex problem","volume":"5","author":"Boutros","year":"1977","journal-title":"Crit. Care Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/ana.25439","article-title":"Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome","volume":"85","author":"Clarkson","year":"2019","journal-title":"Ann. Neurol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.braindev.2019.02.015","article-title":"Early administration of vitamins B1 and B6 and l-carnitine prevents a second attack of acute encephalopathy with biphasic seizures and late reduced diffusion: a case control study","volume":"41","author":"Fukui","year":"2019","journal-title":"Brain Dev."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.braindev.2019.08.007","article-title":"Recent treatment patterns and variations for pediatric acute encephalopathy in Japan","volume":"42","author":"Hayakawa","year":"2020","journal-title":"Brain Dev."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.braindev.2011.11.007","article-title":"Prognostic factors in acute encephalopathy with reduced subcortical diffusion","volume":"34","author":"Hayashi","year":"2012","journal-title":"Brain Dev."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1161\/STROKEAHA.110.592295","article-title":"Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results","volume":"41","author":"Hemmen","year":"2010","journal-title":"Stroke"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/acn3.51308","article-title":"Intrathecal dexamethasone therapy for febrile infection-related epilepsy syndrome","volume":"8","author":"Horino","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.braindev.2020.03.007","article-title":"Efficacy of hypothermia therapy in patients with acute encephalopathy with biphasic seizures and late reduced diffusion","volume":"42","author":"Hoshide","year":"2020","journal-title":"Brain Dev."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.braindev.2023.03.002","article-title":"Treatment of severe acute necrotizing encephalopathy of childhood with interleukin-6 receptor blockade in the first 24 h as add-on immunotherapy shows favorable long-term outcome at 2 years","volume":"45","author":"Hosie","year":"2023","journal-title":"Brain Dev."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1056\/NEJMoa0706930","article-title":"Hypothermia therapy after traumatic brain injury in children","volume":"358","author":"Hutchison","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMoa012689","article-title":"Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest","volume":"346","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e26660","DOI":"10.1097\/MD.0000000000026660","article-title":"Early steroid pulse therapy for children with suspected acute encephalopathy: an observational study","volume":"100","author":"Ishida","year":"2021","journal-title":"Medicine"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.braindev.2020.04.006","article-title":"Epidemiological changes of acute encephalopathy in Japan based on national surveillance for 2014\u20132017","volume":"42","author":"Kasai","year":"2020","journal-title":"Brain Dev."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.braindev.2012.08.005","article-title":"Serum biomarker kinetics with three different courses of HHV-6B encephalitis","volume":"35","author":"Kawamura","year":"2013","journal-title":"Brain Dev."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/adc.2009.180554","article-title":"Determinants of outcomes following acute child encephalopathy and encephalitis: pivotal effect of early and delayed cooling","volume":"96","author":"Kawano","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pediatrneurol.2019.04.009","article-title":"Favorable outcomes with early interleukin 6 receptor blockade in severe acute necrotizing encephalopathy of childhood","volume":"98","author":"Koh","year":"2019","journal-title":"Pediatr. Neurol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"120321","DOI":"10.1016\/j.jns.2022.120321","article-title":"Effect of higher body temperature and acute brain edema on mortality in hemorrhagic shock and encephalopathy syndrome","volume":"439","author":"Kuki","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/acn3.51229","article-title":"Anakinra usage in febrile infection related epilepsy syndrome: an international cohort","volume":"7","author":"Lai","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3345\/kjp.2014.57.6.264","article-title":"Clinical outcome of acute necrotizing encephalopathy in related to involving the brain stem of single institution in Korea","volume":"57","author":"Lee","year":"2014","journal-title":"Korean J. Pediatr."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa1608193","article-title":"Hypothermia for neuroprotection in convulsive status epilepticus","volume":"375","author":"Legriel","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/ped4.12280","article-title":"Plasma exchange therapy for acute necrotizing encephalopathy of childhood","volume":"5","author":"Li","year":"2021","journal-title":"Pediatr. Investig."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.pediatrneurol.2012.08.013","article-title":"Therapeutic hypothermia for febrile infection-related epilepsy syndrome in two patients","volume":"47","author":"Lin","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00003246-197801000-00001","article-title":"Pentobarbital therapy for intracranial hypertension in metabolic coma. Reye's syndrome","volume":"6","author":"Marshall","year":"1978","journal-title":"Crit. Care Med."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pediatrneurol.2012.11.003","article-title":"Efficacy of dextromethorphan and cyclosporine a for acute encephalopathy","volume":"48","author":"Matsuo","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.braindev.2020.08.001","article-title":"Guidelines for the diagnosis and treatment of acute encephalopathy in childhood","volume":"43","author":"Mizuguchi","year":"2021","journal-title":"Brain Dev."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-0404.2007.00809.x","article-title":"Acute encephalopathy associated with influenza and other viral infections","volume":"115","author":"Mizuguchi","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"ref27","first-page":"1897","article-title":"Guideline for the management of influenza associated encephalopathy","volume":"64","author":"Morishima","year":"2006","journal-title":"Nihon Rinsho"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.braindev.2015.09.003","article-title":"Targeted temperature management for acute encephalopathy in a Japanese secondary emergency medical care hospital","volume":"38","author":"Murata","year":"2016","journal-title":"Brain Dev."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.braindev.2022.10.008","article-title":"Changes in the treatment of pediatric acute encephalopathy in Japan between 2015 and 2021: a national questionnaire-based survey","volume":"45","author":"Murofushi","year":"2022","journal-title":"Brain Dev."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1111\/j.1528-1167.2010.02703.x","article-title":"Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES)","volume":"51","author":"Nabbout","year":"2010","journal-title":"Epilepsia"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/ped.12046","article-title":"Therapeutic indicators of acute encephalopathy in patients with complex febrile seizures","volume":"55","author":"Nagase","year":"2013","journal-title":"Pediatr. Int."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1056\/NEJMoa1310519","article-title":"Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest","volume":"369","author":"Nielsen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.braindev.2014.06.005","article-title":"Targeted temperature management of acute encephalopathy without AST elevation","volume":"37","author":"Nishiyama","year":"2015","journal-title":"Brain Dev."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.braindev.2022.03.004","article-title":"Early therapeutic plasma exchange may lead to complete neurological recovery in moderate to severe influenza-associated acute necrotizing encephalopathy","volume":"44","author":"Okajima","year":"2022","journal-title":"Brain Dev."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.braindev.2008.03.005","article-title":"Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin","volume":"31","author":"Okumura","year":"2009","journal-title":"Brain Dev."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jns.2015.11.043","article-title":"Drugs indicated for mitochondrial dysfunction as treatments for acute encephalopathy with onset of febrile convulsive status epileptics","volume":"360","author":"Omata","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/s0140-6736(08)60837-5","article-title":"Induced hypothermia and fever control for prevention and treatment of neurological injuries","volume":"371","author":"Polderman","year":"2008","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ejpn.2019.08.001","article-title":"Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES - two different outcomes","volume":"23","author":"Sa","year":"2019","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"9134","DOI":"10.1038\/s41598-020-66167-7","article-title":"Determinants of outcomes for acute encephalopathy with reduced subcortical diffusion","volume":"10","author":"Sakata","year":"2020","journal-title":"Sci. Rep."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e016675","DOI":"10.1136\/bmjopen-2017-016675","article-title":"Clinical prediction rule for neurological sequelae due to acute encephalopathy: a medical community-based validation study in Harima Japan","volume":"7","author":"Sasaki","year":"2017","journal-title":"BMJ Open"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3346\/jkms.2010.25.3.449","article-title":"Clinical spectrum and prognostic factors of acute necrotizing encephalopathy in children","volume":"25","author":"Seo","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMcps050929","article-title":"Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy","volume":"353","author":"Shankaran","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1100551","DOI":"10.3389\/fneur.2023.1100551","article-title":"Long-term neuropsychological outcomes in children with febrile infection-related epilepsy syndrome (FIRES) treated with anakinra","volume":"14","author":"Shrestha","year":"2023","journal-title":"Front. Neurol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e1431","DOI":"10.1542\/peds.2013-3106","article-title":"Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the ketogenic diet","volume":"134","author":"Singh","year":"2014","journal-title":"Pediatrics"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3174\/ajnr.A1247","article-title":"Excitotoxicity in acute encephalopathy with biphasic seizures and late reduced diffusion","volume":"30","author":"Takanashi","year":"2009","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1212\/WNL.0000000000000120","article-title":"Clinical and radiologic features of encephalopathy during 2011 E coli O111 outbreak in Japan","volume":"82","author":"Takanashi","year":"2014","journal-title":"Neurology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12883-022-02608-2","article-title":"Prognostic effects of treatment protocols for febrile convulsive status epilepticus in children","volume":"22","author":"Tokumoto","year":"2022","journal-title":"BMC Neurol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12883-022-03048-8","article-title":"Time course of serum cytokine level changes within 72 h after onset in children with acute encephalopathy and febrile seizures","volume":"23","author":"Tomioka","year":"2023","journal-title":"BMC Neurol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/ped.12288","article-title":"Cyclosporine for acute encephalopathy with biphasic seizures and late reduced diffusion","volume":"56","author":"Watanabe","year":"2014","journal-title":"Pediatr. Int."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1111\/epi.17391","article-title":"International consensus recommendations for management of new onset refractory status epilepticus (NORSE) including febrile infection-related epilepsy syndrome (FIRES): summary and clinical tools","volume":"63","author":"Wickstrom","year":"2022","journal-title":"Epilepsia"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"116684","DOI":"10.1016\/j.jns.2020.116684","article-title":"Detailed characteristics of acute encephalopathy with biphasic seizures and late reduced diffusion: 18-year data of a single-center consecutive cohort","volume":"411","author":"Yamaguchi","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"155324","DOI":"10.1016\/j.cyto.2020.155324","article-title":"Elevated cytokine, chemokine, and growth and differentiation factor-15 levels in hemorrhagic shock and encephalopathy syndrome: a retrospective observational study","volume":"137","author":"Yamaguchi","year":"2021","journal-title":"Cytokine"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"655074","DOI":"10.3389\/fped.2021.655074","article-title":"The clinical and imaging characteristics associated with neurological sequelae of Pediatric patients with acute necrotizing encephalopathy","volume":"9","author":"Zhu","year":"2021","journal-title":"Front. Pediatr."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1150868\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T03:10:25Z","timestamp":1692673825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1150868\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":54,"alternative-id":["10.3389\/fnins.2023.1150868"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1150868","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"article-number":"1150868"}}